CH de la côte Basque

Running trials

• Recruiting

  Cognitive Remediation Method Using Rhythmic, Vocal and Corporal Musical Learning for Schizophrenia

  NCT07055204· Source

• Not yet recruiting

  Venetoclax in Association With 3+7 and Midostaurin in FLT3-mutated Acute Myeloid Leukemia

  NCT07726576· Phase 1/2· Source

• Recruiting

  Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.

  NCT07299071· Source

• Recruiting

  Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  NCT07166094· Phase 3· Source

• Active, not recruiting

  Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma

  NCT06353022· Phase 2· Source

• Recruiting

  CARE1 Pragmatic Clinical Trial

  NCT06364631· Phase 3· Source

• Recruiting

  EWALL-PH OBSERVARTORY 2022

  NCT07684131· Source

• Active, not recruiting

  Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

  NCT04802590· Phase 2· Source

• Recruiting

  Evaluation of Omentopexy on Gastro-oesophageal Reflux Following Sleeve Gastrectomy

  NCT04994665· Source

• Recruiting

  A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort

  NCT03755726· Source

• Active, not recruiting

  IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome

  NCT03744390· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia1 recruiting
• Acute myeloid leukemia1 recruiting
• Colorectal cancer1 recruiting
• Endometrial cancer1 recruiting
• High blood pressure1 recruiting
• Kidney cancer1 recruiting
• Obesity1 recruiting
• Schizophrenia1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Evaluation of the Success of Prophylactic Enteral Nutrition in Therapeutic Intensification With Autograft of Autologous Hematopoietic Cells in Hematology

  NCT04703985· Source

• Terminated

  Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia

  NCT03765541· Phase 3· Source

• Completed

  PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMA

  NCT03006432· Phase 3· Source